Bank of Montreal Can Has $515,000 Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Bank of Montreal Can lowered its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 58.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 22,190 shares of the company’s stock after selling 31,175 shares during the period. Bank of Montreal Can’s holdings in Option Care Health were worth $515,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Barclays PLC lifted its holdings in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after purchasing an additional 199,454 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in shares of Option Care Health by 6.9% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock worth $234,000 after buying an additional 650 shares during the period. Nordea Investment Management AB raised its holdings in Option Care Health by 6.0% in the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company’s stock valued at $2,165,000 after acquiring an additional 5,365 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of Option Care Health by 2.7% during the fourth quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company’s stock worth $4,945,000 after acquiring an additional 5,595 shares during the period. Finally, Graypoint LLC acquired a new position in shares of Option Care Health in the fourth quarter valued at approximately $1,161,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on OPCH. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Monday. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $31.25 on Tuesday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market cap of $5.13 billion, a price-to-earnings ratio of 26.26, a PEG ratio of 2.30 and a beta of 1.07. The firm has a 50 day simple moving average of $33.32 and a 200 day simple moving average of $28.66.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.